✦ LIBER ✦

CCN3: a novel anti-fibrotic treatment in end-stage renal disease?

✍ Scribed by Andrew Leask

Book ID: 113094706
Publisher: Springer Netherlands
Year: 2012
Tongue: English
Weight: 74 KB
Volume: 6
Category: Article
ISSN: 1873-9601
DOI: 10.1007/s12079-012-0162-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of hyperhomocysteinemia in end

Treatment of hyperhomocysteinemia in end-stage renal disease

✍ Douglas Shemin; Andrew G. Bostom; Jacob Selhub 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Renal transplantation in anti–HCV-positi

Renal transplantation in anti–HCV-positive patients with end-stage renal disease

✍ F.A.M Shaheen; I.A Sheikh; A Mutwalli; A Al-Khader 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 112 KB

CCN3 (NOV) Is a Negative Regulator of CC

CCN3 (NOV) Is a Negative Regulator of CCN2 (CTGF) and a Novel Endogenous Inhibitor of the Fibrotic Pathway in an in Vitro Model of Renal Disease

✍ Bruce L. Riser; Feridoon Najmabadi; Bernard Perbal; Darryl R. Peterson; Jo Ann R 📂 Article 📅 2009 🏛 American Society for Investigative Pathology 🌐 English ⚖ 642 KB

Hemofiltration as a treatment for end-st

Hemofiltration as a treatment for end-stage renal disease

✍ Deborah L Zimmerman 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

End-stage renal disease in fabry disease

✍ A. Granata; G. Romeo; S. Gulisano; G. Leonardi; R. Romano; E. Manca; A. Fiumara; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Treatment Bias in the Management of End-

Treatment Bias in the Management of End-Stage Renal Disease

✍ Smith, Marc D.; Hong, Barry A.; Michelman, Jeffrey E.; Robson, Alan M. 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 519 KB